Literature DB >> 17566724

Trastuzumab in patients on haemodialysis for renal failure.

R A Micallef, P J Barrett-Lee, K Donovan, M Ashraf, L Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17566724     DOI： 10.1016/j.clon.2007.04.008

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  5 in total

Review 1.  Practical guidelines for dose individualization of anticancer targeted drugs.

Authors:  María Isabel Sáez; Cristina Quero; José Manuel Trigo; Begoña Muros; Emilio Alba
Journal:  Clin Transl Oncol       Date:  2012-10-12       Impact factor: 3.405

Review 2.  Renal effects of targeted anticancer therapies.

Authors:  Camillo Porta; Laura Cosmai; Maurizio Gallieni; Paolo Pedrazzoli; Fabio Malberti
Journal:  Nat Rev Nephrol       Date:  2015-03-03       Impact factor: 28.314

Review 3.  Renal toxicity of anticancer agents targeting HER2 and EGFR.

Authors:  Laura Cosmai; Maurizio Gallieni; Camillo Porta
Journal:  J Nephrol       Date:  2015-09-04       Impact factor: 3.902

4.  Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature.

Authors:  Peter Barth; Essel Dulaimi Al-Saleem; Kristin W Edwards; Sherri Z Millis; Yu-Ning Wong; Daniel M Geynisman
Journal:  Case Rep Oncol Med       Date:  2015-01-27

5.  Individualized treatment of breast cancer with chronic renal failure: A case report and review of literature.

Authors:  Jie-Hui Cai; Jie-Hua Zheng; Xiao-Qi Lin; Wei-Xun Lin; Juan Zou; Yao-Kun Chen; Zhi-Yang Li; Ye-Xi Chen
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.